Short interest in Viridian Therapeutics Inc (NASDAQ:VRDN) decreased during the last reporting period, falling from 9.10M to 8.75M. This put 12.55% of the company's publicly available shares short.

Short interest for Viridian Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Viridian Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 999.99K shares traded per day, it would take 8.75 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.